Clinical Study | Office of Clinical Research

Rtog-1308: Phase III Randomized Trial Comparing Overall Survival After Photon Versus Proton Chemoradiotherapy For Inoperable Stage II-IIIb Nsclc

Posted Date: Sep 28, 2020

Investigator: Emily Daugherty
Specialties: Cancer, Lung Cancer, Oncology, Pulmonary Diseases, Radiation Oncology
Type of Study: Device

To compare the overall survival (OS) in patients with stage II-IIIB NSCLC Photon (X-Ray) radiation therapy (Arm 1) versus Proton radiation therapy (Arm 2) both given with concurrent platinum-based chemotherapy

Criteria:

Newly Diagnosed Stage Ii To Stage Iiib Non-Small Cell Lung Cancer Which Is Not Surgically Removed

Keywords:

Proton Therapy, Lung Cancer, Radiation Therapy

For More Information:

Dr. Emily Daugherty, Md
513-584-4073
daugheec@ucmail.uc.edu

Name*
First Last
Gender*
- Male
- Female
Age*
Phone*
Email*
How did you hear about us?*
Future Communication*
- By submitting this form, I am agreeing to receive future communication about participating in an upcoming research study.
CAPTCHA
This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
For questions regarding clinical studies at UC Health, contact us at ResearchStudies@UCHealth.com or (513) 245-3417.
List